Scarica l'app Stockscreener
25.87
4.15%
1.03
Precedente Chiudi:
$24.84
Aprire:
$24.72
Volume 24 ore:
772.67K
Relative Volume:
0.64
Capitalizzazione di mercato:
$1.21B
Reddito:
$82.71M
Utile/perdita netta:
$-102.24M
Rapporto P/E:
-7.049
EPS:
-3.67
Flusso di cassa netto:
$-76.57M
1 W Prestazione:
+8.88%
1M Prestazione:
+42.61%
6M Prestazione:
+520.38%
1 anno Prestazione:
+123.98%
Intervallo 1D:
$24.69
$26.09
Intervallo di 1 settimana:
$22.70
$26.28
Portata 52W:
$3.42
$26.28
Urogen Pharma Ltd Stock (URGN) Company Profile
Nome
Urogen Pharma Ltd
Settore
Industria
Telefono
972 9 770 7601
Indirizzo
9 HA'TA'ASIYA ST, RA'ANANA
Confronta URGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
URGN
Urogen Pharma Ltd
|
25.87 | 1.16B | 82.71M | -102.24M | -76.57M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Urogen Pharma Ltd Stock (URGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-06-16 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-05-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-04-16 | Iniziato | Scotiabank | Sector Outperform |
| 2025-02-19 | Ripresa | Ladenburg Thalmann | Buy |
| 2024-08-22 | Iniziato | Guggenheim | Buy |
| 2023-02-08 | Downgrade | Jefferies | Buy → Hold |
| 2022-04-27 | Iniziato | Berenberg | Buy |
| 2020-04-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-13 | Reiterato | H.C. Wainwright | Buy |
| 2020-01-09 | Iniziato | National Securities | Neutral |
| 2019-05-30 | Iniziato | JP Morgan | Neutral |
| 2019-05-29 | Iniziato | Goldman | Neutral |
| 2019-01-29 | Iniziato | H.C. Wainwright | Buy |
| 2018-11-08 | Ripresa | Jefferies | Buy |
| 2018-04-04 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-01-02 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-11-15 | Reiterato | Oppenheimer | Outperform |
| 2017-11-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
Mostra tutto
Urogen Pharma Ltd Borsa (URGN) Ultime notizie
Will UroGen Pharma Ltd. stock attract more institutional investors2025 Sector Review & Fast Exit/Entry Strategy Plans - newser.com
UroGen Pharma CMO Schoenberg sells $250,000 in shares By Investing.com - Investing.com South Africa
UroGen Pharma CMO Schoenberg sells $250,000 in shares - Investing.com
Does UroGen Pharma Ltd. stock trade at a discount to peersQuarterly Performance Summary & High Accuracy Swing Entry Alerts - newser.com
Will UroGen Pharma Ltd. (UR8) stock sustain dividend payoutsOptions Play & Precise Trade Entry Recommendations - newser.com
Is UroGen Pharma Ltd. (UR8) stock prepared for digital transitionEarnings Miss & Real-Time Volume Triggers - newser.com
Is UroGen Pharma Ltd. (UR8) stock undervalued after correction2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com
Urogen Pharma Ltd stock hits 52-week high at 25.2 USD - Investing.com Nigeria
Will UroGen Pharma Ltd. (UR8) stock gain from green policiesQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com
Why global investors buy UroGen Pharma Ltd. (UR8) stockWeekly Market Summary & Safe Capital Allocation Plans - newser.com
Is UroGen Pharma Ltd. (UR8) stock good for long term investing2025 EndofYear Setup & Safe Entry Zone Tips - newser.com
Why UroGen Pharma Ltd. (UR8) stock stays on buy listsShort Setup & Safe Entry Momentum Stock Tips - newser.com
UroGen Pharma (URGN) Closes Q3 2025 With $127.4 Million in Cash Amid Rising R&D Costs - MSN
Why UroGen Pharma Ltd. stock could be next big winner2025 Risk Factors & Smart Money Movement Alerts - newser.com
UroGen Pharma Ltd Stock Analysis and ForecastCapital Gains Strategies & Free High Yield Portfolio Picks - earlytimes.in
Is UroGen Pharma Ltd. stock bottoming outDividend Hike & Expert Approved Momentum Trade Ideas - newser.com
UGN-103 Phase 3 Success and FDA Support Could Be a Game Changer for UroGen Pharma (URGN) - simplywall.st
Urogen Pharma Ltd Azioni (URGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):